Trial intelligence / Profile preview

Remimazolam versus propofol for anesthesia in elderly patients undergoing ureteroscopic laser lithotripsy

ChiCTR2100050300Phase 4Recruiting

Sponsor
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of remimazolam and propofol in Lithiasis (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Vital sign fluctuation, Dose and frequency of vasoactive drugs and 1 more. Started Aug 2021; status: recruiting.

02

Drugs

remimazolampropofol
03

Conditions

Lithiasis

Beyond the preview

Go deeper on ChiCTR2100050300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100050300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call